Drugs / NoV GI.1/GII.4 Bivalent VLP Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02669121 | Jun 2016 → Jun 2018 | — | Takeda | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NoV GI.1/GII.4 Bivalent VLP Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02669121 ↗ |
| Modality | Vaccine | “NoV GI.1/GII.4 bivalent virus-like particle (VLP) vaccine” NCT02669121 ↗ |
| Route | Intramuscular | “intramuscularly (IM)” NCT02669121 ↗ |